containing two or more 4-oxo-1,4-dihydropyridine-2-carboxylic acid units fused to a central aromatic nucleus was synthesized and tested in the rat passive cutaneous anaphylaxis (PCA) assay for potential antiallergy activity. Most of the compounds of this series showed significant activity in the PCA assay. Three of these compounds. 11d, 13f, and 21, were more than 250 times as active as the standard drug, cromolyn
合成了一系列包含两个或多个与中心芳香核融合的4-氧代-1,4-
二氢吡啶-2-
羧酸单元的化合物,并在大鼠被动皮肤过敏反应(PCA)分析中测试了其潜在的抗过敏活性。该系列的大多数化合物在PCA分析中显示出显着的活性。这些化合物中的三种。11d,13f和21的活性是标准药物cromolyn
钠的250倍以上。讨论了合成和
生物活性。